Engineers Gate Manager’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.12M | Buy |
+24,070
| New | +$1.16M | 0.01% | 1018 |
|
|
2025
Q3 | – | Sell |
-22,963
| Closed | -$724K | – | 2514 |
|
|
2025
Q2 | $724K | Buy |
22,963
+4,926
| +27% | +$158K | 0.01% | 1288 |
|
|
2025
Q1 | $591K | Buy |
18,037
+4,744
| +36% | +$168K | 0.01% | 1364 |
|
|
2024
Q4 | $481K | Sell |
13,293
-1,417
| -10% | -$49.9K | 0.01% | 1453 |
|
|
2024
Q3 | $459K | Buy |
+14,710
| New | +$459K | 0.01% | 1415 |
|
|
2024
Q2 | – | Sell |
-18,174
| Closed | -$620K | – | 2229 |
|
|
2024
Q1 | $620K | Sell |
18,174
-4,618
| -20% | -$137K | 0.02% | 1087 |
|
|
2023
Q4 | $660K | Buy |
+22,792
| New | +$604K | 0.02% | 1034 |
|
|
2023
Q1 | – | Sell |
-5,868
| Closed | -$209K | – | 1986 |
|
|
2022
Q4 | $209K | Buy |
+5,868
| New | +$204K | 0.01% | 1356 |
|
|
2021
Q1 | – | Sell |
-41,357
| Closed | -$1.04M | – | 2114 |
|
|
2020
Q4 | $1.04M | Buy |
41,357
+30,745
| +290% | +$662K | 0.05% | 583 |
|
|
2020
Q3 | $221K | Sell |
10,612
-9,815
| -48% | -$223K | 0.01% | 1390 |
|
|
2020
Q2 | $485K | Buy |
+20,427
| New | +$451K | 0.02% | 963 |
|
|
2020
Q1 | – | Sell |
-162,156
| Closed | -$3.85M | – | 1919 |
|
|
2019
Q4 | $3.85M | Buy |
+162,156
| New | +$3.94M | 0.17% | 144 |
|
|
2019
Q2 | – | Sell |
-39,731
| Closed | -$1.39M | – | 1368 |
|
|
2019
Q1 | $1.39M | Sell |
39,731
-5,466
| -12% | -$203K | 0.08% | 351 |
|
|
2018
Q4 | $1.5M | Buy |
+45,197
| New | +$1.94M | 0.12% | 259 |
|
|
2018
Q3 | – | Sell |
-54,903
| Closed | -$3.29M | – | 1160 |
|
|
2018
Q2 | $3.29M | Sell |
54,903
-13,019
| -19% | -$674K | 0.26% | 115 |
|
|
2018
Q1 | $3.11M | Buy |
67,922
+24,155
| +55% | +$1.01M | 0.21% | 160 |
|
|
2017
Q4 | $1.74M | Sell |
43,767
-5,923
| -12% | -$234K | 0.12% | 313 |
|
|
2017
Q3 | $1.99M | Sell |
49,690
-23,420
| -32% | -$1.01M | 0.17% | 221 |
|
|
2017
Q2 | $3.15M | Buy |
73,110
+29,838
| +69% | +$1.06M | 0.28% | 114 |
|
|
2017
Q1 | $1.35M | Buy |
+43,272
| New | +$1.16M | 0.13% | 283 |
|
|
2016
Q4 | – | Sell |
-53,849
| Closed | -$1.33M | – | 719 |
|
|
2016
Q3 | $1.33M | Buy |
53,849
+2,884
| +6% | +$65.3K | 0.14% | 278 |
|
|
2016
Q2 | $1.04M | Buy |
50,965
+37,285
| +273% | +$661K | 0.07% | 419 |
|
|
2016
Q1 | $209K | Buy |
+13,680
| New | +$178K | 0.02% | 618 |
|
|
2015
Q4 | – | Sell |
-99,520
| Closed | -$1.4M | – | 788 |
|
|
2015
Q3 | $1.4M | Buy |
99,520
+20,569
| +26% | +$382K | 0.12% | 291 |
|
|
2015
Q2 | $1.34M | Buy |
78,951
+65,203
| +474% | +$928K | 0.13% | 269 |
|
|
2015
Q1 | $166K | Buy |
+13,748
| New | +$130K | 0.02% | 867 |
|
Other funds holding SUPN
AC
NAMI
SIMG
Engineers Gate Manager's SUPN Position: Q2 2026 in Review
Engineers Gate Manager opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 24,070 shares worth $1.12M. The stake represents 0.01% of the portfolio and ranks #1018 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in SUPN as recently as Q2 2025.
Engineers Gate Manager first reported a position in SUPN in Q1 2015 and has held it in 26 quarters since. The position peaked at $3.85M in Q4 2019. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Engineers Gate Manager held 24,070 shares of Supernus Pharmaceuticals worth $1.12M as of Q2 2026.
- Supernus Pharmaceuticals was a new Engineers Gate Manager position in Q2 2026.
- Supernus Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1018 holding.
- Engineers Gate Manager first reported a position in Supernus Pharmaceuticals in Q1 2015 and has held it in 26 quarters since.
- Engineers Gate Manager's Supernus Pharmaceuticals position peaked at $3.85M in Q4 2019.
- 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.